Influence of low protein diet on progression of chronic renal failure
Abstract
Еще в 1869 г. L. Beale [23] писал, что ограничение потребления белка облегчает состояние больных с нарушенной функцией почек, а F. Volhard [154] указывал, что у больных с хронической почечной недостаточностью (ХПН) «возможно отсрочить» повышение концентрации мочевины в крови на длительный период времени, уменьшая потребление азота до 3-5 г/сут (20-30 г/сут белка). В ряде случаев ему удавалось, ограничивая потребление белка, снизить высокий уровень мочевины в крови, что сопровождалось исчезновением симптомов уремии. L. Ambard, известный своими работами в области физиологии и патофизиологии почек, в 1909 г. предложил определять «дебит мочевины» - произведение концентрации мочевины на диурез в соотношении к уровню мочевины в крови. В норме константа Ambard равнялась 0,07, а ее увеличение характеризовало степень нарушения функции почек. Двумя годами позднее он отмечал, что больные с уремией часто выглядят истощенными и усугубляют свое состояние, если употребляют в пищу мясо [5].
About the Authors
V. M. Ermolenko
РМАПО, г. Москва
Russian Federation
Russian Federation
T. A. Kozlova
РМАПО, г. Москва
Russian Federation
Russian Federation
N. A. Michailova
РМАПО, г. Москва
Russian Federation
Russian Federation
References
1. Береснева О.Н., Парастаева М.М., Иванова Г.Т. и соавт. Роль кетостерила в нефропротекции и кардиопротекции при экспериментальной уремии. Нефрология 2006; 1: 56-62.
2. Тареева И.Е., Кутырина И.М., Николаев А.Ю. и др. Пути торможения развития хронической почечной недостаточности. Тер. архив 2000; 6: 9-14.
3. Чеботарева Н.В. Бобкова И.Н., Козловская Л.В. Молекулярные механизмы интерстициального фиброза при прогрессирующих заболеваниях почек. Нефрология и диализ 2006; 1: 26-36.
4. Agus D., Mann R., Cohn D. et al. Inhibitory role of dietary protein restriction on the development and expression of immune mediated antitubular basement membrano-induced tubulointerstitial nephritis in rats. J Clin Investig 1985; 76: 930-936.
5. Ambard L. Physiologie Normale et Phathologie des Reins. Paris, Masson et Cie 1920: 264.
6. Aparicio M., Potaux L., Precigout V. et al. Hypertriglyceridemia and low-phosphorus, low-nitrogen diet in patient with chronic renal failure. Nephron 1987; 46: 335-336.
7. Aparicio M., Bouchet J., Gin H. et al. Effect of a low-protein diet on urinary albumin excretion in uremic patients. Nephron 1988; 50: 288-291.
8. Aparicio M., Vincendeau Ph., Gin H. et al. Effect of a low-protein diet on chemiluminescence production by leukocytes from uremic patients. Nephron 1988; 48: 315-318.
9. Aparicio M., Gin H., Potaux L. et al. Effect of ketoacid diet on glucose tolerance and tissue insulin sensitivity. Kidney int 1989; 36; Suppl. 27: 231-235.
10. Aparicio M., Gin H., de Precigout V. et al. Complaince with low protein diet by uremic patients: three years' experience. Contrib Nephrol 1990; 81: 71-78.
11. Aparicio M., Lafage M.H., Combe C. et al. Low-protein diet and renal osteodystrophy. Nephron 1991; 58: 250-252.
12. Aparicio M., Lafage M.H., Combe C. и cоавт. Метаболические эффекты низкобелковой низкофосфорной диеты у больных с хронической почечной недостаточностью. Клин. фармакол. тер. 1996; 2: 15-18.
13. Avram M., Shreedhara R. Fein P. et al. Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters. Am J Kidney Dis 2001; 37: S77-S80.
14. Arai J., Hara Y., Fukuda S. et al. Metabolic conversion of a-keto valine to valine in patients with chronic renal failure. Clin Nephrol 1985; 23: 236-240.
15. Barrientos A., Arteaga J., Rodicio L. et al. Role of the control of phosphate in the progression of chronic renal failure. Mineral Electrolyte Metab 1982; 7: 127-133.
16. Barsotti G., Morelli E., Guiducci A. et al. Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet. Nephron 1982; 30: 310-313.
17. Barsotti G., Morelli E., Cupisti A. et al. Restricted phosphorus and nitrogen intake to slow the progression of chronic renal failure: a controlled trial. Kidney int 1983; 24; Suppl. 16: 278-284.
18. Barsotti G., Gainnoni A., Morelli E. et al. The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet. Clin Nephrol 1984; 21: 54-59.
19. Barsotti G., Cristofano C., Morelli E. et al. Serum oxalis acid in uremia: effect of a low-protein diet supplemented with essential amino acids and ketoanalogues. Nephron 1984; 38: 54-56.
20. Barsotti G., Ciardella F., Morelli E. et al. Restoration of blood levels of testosterone in male uremics following a low-protein diet supplemented with essential amino acids and ketoanalogues. Contr Nephrol 1985; 49: 63-69.
21. Barsotti G., Ciardella F., Morelli E. et al. Nutritional treatment of renal failure in type 1 diabetic nephropathy. Clin Nephrol 1988; 29: 280-287.
22. Barsotti G., Moriconi L., Cupisti A. et al. Protection of renal function and nutritional status in uraemic rats by means of a low-protein, low-phosphorus supplemented diet. Nephron 1988; 49: 197-202.
23. Beale L. Kidney diseases, urinary deposits and calculous disorders. Their nature and treatment. Philadelphia, -Lindsay and Blakiston 1869.
24. Beddhu S., Samore M., Roberts M. et al. Impact of initiation of dialysis on mortality. J Am Soc Nephrol 2003; 14: 2305-2312.
25. Bending J., Dodds R., Keen H. et al. Renal response to restriction protein intake in diabetic nephropathy. Diabetologia 1988; 3: 1641-1646.
26. Bеrgesio F., Monzani G., Guasparini A. et al. Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment. Clin Nephrol 2005; 64: 103-112.
27. Berlyne G., Shaw A., Nilwarngkur S. Dietary treatment of chronic renal failure. Experience with modified Giovannetti diet. Nephron 1965; 2: 129-147.
28. Bernard S., Fongue D., Laville M., Zech P. Effects of low protein diet supplemented with ketoacids on plasma lipids in adult chronic renal failure. Miner Electrolite Metab 1996; 22: 143-146.
29. Blumenkrantz M., Kopple J. VA cooperative dialysis study participants: incidence of nutritional abnormalities in uremic patients entering dialysis therapy. Kidney int 1976; 10: 514.
30. Bonomini V., Felleti C., Scolary M., Stefani S. Benefits of early initiation of dialysis. Kidney int 1985; 28 (Suppl. 17): S57-S59.
31. Bradford J. The results following partial nephrectomy and the influence of the kidney metabolism. J Physiol 1899; 23: 415.
32. Brenner B., Meyer T., Hostetter T. Dietary protein intake and the progressive nature of kidney disease: the role hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease. N Engl J Med 1982; 307: 652-659.
33. Brenner B. Hemodynamically mediated glomerular injury and the progressive nature of renal disease. Kidney int 1983; 23: 647-655.
34. Brenner B. Nephron adaptation to renal injuri or ablation. Am J Physiol 1985; 249: F324.
35. Chade A., Lerman A., Lerman L. Kidney in early atherosclerosis. Hypertension 2005; 45: 1042-1049.
36. Chanutin A., Ferris E. Experimental renal insufficiency produced by partial nephrectomy. I Control diet. Arch int Med 1936; 58: 60.
37. Chauveau Ph., Lebkiri B., Ployard F. et al. Effect des cetoanalogues des acides amines essentials sur la progression de l'insuffisance renale chronique avancee: etude prospective controlee. Nephrologie 1986; 4: 137-142.
38. Churchull D. An evidence-based approach to earlier initiation of dialysis. Am J Kidney Dis 1997; 30: 899-906.
39. Ciardella F., Morelli E. Niosi F. et al. Effect of a low-phosphorus, low nitrogen diet supplemented with essential amino acids and ketoanalogues on serum triglycerides of chronic uremic patients. Nephron 1986; 42: 196-199.
40. Ciardella F., Morelli E., Cupisti A. et al. Metabolic effects of very low protein low phosphorus diet supplemented with essential amino acids and ketoanaloges in end-stage renal diseases. Contr Nephrol 1988; 65: 72-88.
41. Claris-Appiani A., Assael B., Tirelli A. Lack of glomerular hemodynamic stimulation after infusion of branched-chain amino acids. Kidney int 1988; 33: 91-94.
42. Cohen D., Dodds R., Viberti G. Effect protein restriction in insulin dependent diabetics at risk of nephropathy. Br Med J 1987; 294: 795-798.
43. Coresh J., Walser M., Hill S. Survival on dialysis among chronic renal failure patients treated with a supplemented low-protein diet before dialysis. J Am Soc Nephrol 1995; 6: 1379-1385.
44. Corman B., Chami-Khazraji S., Schaeverbeke J., Michel J. Effect of feeding on glomerular filtration in conscious aging rats. Am J Physiol 1988; 255: F250-F256.
45. Cupisti A., Carulli G., Polidori R. et al. Superoxide anion prodution and dietary treatment in chronic renal failure. Nephron 1991; 57: 119-120.
46. Di Iorio B., Minutolo R., De Nicola L. et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney int 2003; 64: 1822-1828.
47. El-Nahas A., Masters-Thomas A., Brady S. et al. Selective of low protein diet in chronic renal diseases. Brit Med J 1984; 289:1337-1341.
48. Evanoff G., Thompson C., Brown J. et al. The effect of protein restriction on the progression diabetic nephropathy. A 12-month follow-up. Arch int Med 1987; 147: 492-495.
49. Fera H. Fünf Sprachen unter einem Hut (Verlage für Volkstum, Berlin: 1939).
50. Fioretti P., Melis G., Ciardella F. et al. Parathyreoid function and pituitary-gonadal axis in male uremics; effects of dietary treatment and of maintenance hemodialysis. Clin Nephrol 1986; 25: 155-158.
51. Fouque D., Wang P., Laville M. et al. Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. Nephrol Dial Trasplant 2000; 15: 1986-1992.
52. Fröhling P., Kokot F., Schmicker R. et al. Influence of ketoacids on serum parathyroid hormone levels in patients with chronic renal failure. Clin Nephrol 1983; 20: 212-215.
53. Fröhling P., Schmidt-Gayk H., Kokot F. et al. Influence of vitamin D and keto acids (KA) on 1,25(OH)2D levels in patient with chronic renal failure. Vitamin D: Chem Biochem and Clin Update. Proc 6th workshop. Merano, Berlin, 17-22 March, 1985: 952-953.
54. Fröhling P., Krupki F., Kokot F. et al. What are the most important factors in the progression of renal failure? Kidney int 1989; 36; Suppl. 27: S106-S109.
55. Garibotto Q., Russo R., Sifia A. et al. Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney int 1994; 45: 1432-1439.
56. Gin H., Aparicio M., Potaux L. et al. Low-protein and low phosphorus diet in patients with chronic renal failure: influence on glucose tolerance and tissue insulin sensitivity. Metabolism 1987; 36: 1080-1085.
57. Gin H., Aparicio M., Potaux L. et al. Low-protein, low-phosphorus diet and tissue insulin sensitivity in insulin-dependent diabetic patients with chronic renal failure. Nephron 1991; 57: 411-415.
58. Gin H., Combe C., Rigallean V. et al. Effects of low-protein, low-phosphorus diet on metabolic insulin clearance in patients with chronic renal failure. Am J Clin Nutr 1994; 59: 663-666.
59. Giordano C. The use of exogenous and endogenous urea for protein in normal and uremic subjects. J Lab Clin Med 1963; 62: 231.
60. Giovanetti S., Maggiore Q. A low nitrogen diet with proteins of high biological value for severe chronic uremia. Lancet 1964; 1: 1000-1003.
61. Giovanetti S. Unwanted side effects of nutritional therapy for patients with chronic renal failure. In book: Nutritional treatment of chronic renal failure. Oxford: Kluwer 1989: 267.
62. Glasser R., Velosa J., Michael A. Experimental model of focal sclerosis. Lab Investing 1977; 36: 519-526.
63. Graham K., Reaich D., Channon S. et al. Correction acidosis in CAPD decrease whole body protein degradation. Kidney int 1996; 49: 1396-1400.
64. Grützmacher P., März W., Peschke B. et al. Lipoproteins and apolipoproteins during progression of chronic renal disease. Nephron 1988; 50: 103-111.
65. Goodship T., Mitch W., Hoerr R.A. et al. Adaption to low protein diets in renal failure: turnover and nitrogen balance. J Am Soc Nephrol 1990; 3: 66-75.
66. Haeberie K. Physiological aspects of low protein diet therapy. Blood Purif 1989; 7: 32-42.
67. Hakim R., Lazarus J. Initiation of dialysis. J Am Soc Nephrol 1998; 9: 596-599.
68. Halliburton J., Thomson R. Clinical aspects of compensatory renal hypertrophy. Cancer Res 1965; 25: 1882-1887.
69. Hansen H., Tauber-Lassen B., Jensen B. et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney int 2002; 62: 220-228.
70. Hara Y., May R., Kelly R., Mitch W. Acidosis, not azotemia stimulates branched-chain amino acid catabolism in uremic rats. Kidney int 1987; 32: 808-814.
71. Harris D., Chan L., Schrier R. Remnant kidney hypermetabolism and progression of chronic renal failure. AmJ. Physiol 1988; 254: F267-F276.
72. Haut L., Alfrey A., Guggenheim S. et al. Renal toxicity of phosphate in rats. Kidney int 1980; 17: 722-731.
73. Heidland A., Kult J. Long-term effects of essential amino acid supplemention in patients on regular dialysis treatment. Clin Nephrol 1975; 3: 235-239.
74. Heifets M., Morrissey J., Purkerson M. et al. Effect of dietary lipids on renal function in rats with subtotal nephrectomy. Kidney int 1989; 35: 40-47.
75. Hirschberg R., Cohen A., Kopple J. Effects of keto acid supplements on renal function and histology in azotemic rats fed high-protein diets. Am J Nephrol 1988; 8: 50-55.
76. Ibels L., Alfrey A., Haut L. et al. Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med 1978; 298: 122-126.
77. Ihle B., Becker G., Whitworth J., Charlwood R., Kincaid-Smith P. The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 1989; 321: 1773-1777.
78. Ikizler T., Green J., Wingard R. et al. Spontaneous dietary intake during progression of chronic renal failure. J Am Soc Nephrol 1995; 6: 1386-1391.
79. Ikizler T., Pupim L., Bronilette J. et al. Hemodialysis stimulate muscle and whole body protein loss and alters substrate oxidation. Am Physiol Endocrinol Metab 2002; 282: E107-116.
80. Ingale A., Ingale F., Kulkarni H. Unexpected rise in GFR in a patient of chronic kidney disease with single functioning kidney following keto-diet: a case report. Am J Nephrol 2004; 24: 61.
81. Ishikava I., Purkerson M., Klahr S. et al. Mechanism of reduced glomerular filtration rats in chronic malnutrition. J Clin Investig 1980; 65: 982-988.
82. Ishikava I., Purkerson M., Yates J., Klahr S. Dietary protein intake conditions the degree of renal vasoconstriction in acute renal failure caused by ureteral obstruction. Am J Physiol 1985; 249: F54-F57.
83. Jones M., Kopple J. Valine metabolism in normal and chronically uremic man. Am J Clin Nutr 1978; 31: 1660-1664.
84. Jungers P., Chauveau Ph., Ployard F. et al. Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney int 1987; 32; Suppl. 22: S67-S71.
85. Kaysen G. Hyperlipidemia of chronic renal failure. Blood Purif 1994; 12: 60-67.
86. Kasiske B., Lakatna J., Ma J., Louis T. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998; 31: 954-961.
87. Keane W., Kasiske B., O'Donell M. Hyperlipidemia and the progression of renal disease. Am J Clin Nutr 1988; 47: 157-160.
88. Keane W., Kasiske B., O'Donell M. Lipids and progressive glomerulosclerosis. Am J Nephrol 1988; 8: 261-281.
89. Kenner Ch., Evan A., Bromgren Ph. et al. Effect of protein intake on renal function and structure in partially nephrectomized rats. Kidney int 1985; 27: 739-750.
90. King A., Levey A. Dietary proteins and renal function. JASN 1993; 3: 1723-1737.
91. Klahr S., Tripathy K. Evaluation of renal function in malnutrition. Arch Int Med 1966; 118: 322-325.
92. Klahr S., Levey A., Beck G. et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 877-884.
93. Kleinknecht C., Laounari D., Thorel D. et al. Protein diet and uremic toxicity: myth or reality? Kidney int 1987; 32; Suppl. 22: 62-66.
94. Kopple J., Coburn J. Metabolic studies of low protein diets in uremia: I. Nitrogen and potassium. Medicine 1973; 52: 583-595.
95. Kopple J., Swendseid M. Protein and aminoacid metabolism in uremic patients undergoing maintenance hemodialysis. Kidney int 1975; 7: S64-S72.
96. Kopple J., Monteon F., Shaib J. Effects of energy intake on nitrogen metabolism in nondialysed patients with chronic renal failure. Kidney int 1986; 22: 48-53.
97. Кopple J., Levey A., Greene T. et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease study. Kidney int 1997; 52: 778-779.
98. Kronenberg F., Utermann G., Dieplinger H. Lipoprotein(a) in renal desease. Am J Kidney Dis 1996; 27: 1-25.
99. Lafage M.H., Combe Ch., Fournier A., Aparicio M. Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy. Kidney int 1992; 42: 1217-1225.
100. Laouari D., Kleinknecht C., Habib R. et al. The roles of phosphorus deficiency and low food intake in the preservation of renal function in uraemic rats. Experientia 1982; 38; 6: 681-682.
101. Laouari D., Kleinknecht C., Broyer M. Utilisation des keto-analogues d'acides amines dans l'insuffisance renale chronique. Nephrologie 1986; 7: 133-137.
102. Laouari D., Rocchiccioli F., Dodu C. et al. Conversion of two branched-chain a-ketoanalogs in normal and uremic rats. Kidney int 1987; 32; Suppl. 22: S186-S190.
103. Lim V., Kopple J. Protein metabolism in patients with chronic renal failure. Role of uremia and dialysis. Kidney int 2000; 58: 1-10.
104. Lindenau K., Kokot F., Fröhling T. Supression of parathyroid hormone by therapy with a mixture of keto analogues/amino acidis in hemodialysis patient. Nephron 1986; 43: 84-86.
105. Lindenau K., Abendroth K., Kokot F. et al. Therapeutic effect of keto-acids on renal osteodystrophy. Nephron 1990; 55: 113-135.
106. Locatelli F., Marselli D., Ponti R. et al. Effect of low protein diet on the progression of adult dominant polycystic kidney disease. Seminar on cystic renal disease. Milano: 1989: 47-52.
107. Locatelli F., Alberti D., Graziani G. et al. Prospective, randomised, multicentre trail of effect of protein restriction on progression of chronic renal insufficiency. Lancet 1991; 337: 1299-1304.
108. Loschiavo C., Ferrari S., Panebianco R. et al. Effect of protein-restricted diet on serum lipids and atherosclerosis risk factors in patients with chronic renal failure. Clin Nephrol 1988; 29: 113-118.
109. Lucas P.A., Brown R.C., Woodhead J.S. et al. 1,25-dihydroxycholecalciferol and parathyroid hormon in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction. Clin Nephrol 1986; 25: 7-10.
110. Lucas Ph., Meadows J., Roberts D. et al. The risk and benefits of a low protein-essential amino acid-keto acid diet. Kidney int 1986; 29: 995-1003.
111. Lumlertgul D., Bruke T., Gillum D. et al. Phosphate depletion arrests progression of chronic renal failure independent of protein intake. Kidney int 1986; 29: 658-666.
112. Maroni B. Protein restriction and malnutrition in renal disease: fact of fiction? Miner Electrolyte Metab 1997; 23: 225-228.
113. Maroni B., Staffeld C., Young V. et al. How is lean body mass concerved with the very low protein regimen? Miner Electrolyte Metab 1996; 22: 54-57.
114. Maroni B. Impact of chronic renal failure on nitrogen metabolism. Miner Electrolyte Metab 1998; 24: 34-40.
115. Maschio G., Oldriggi L., Tessitore N. et al. Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney int 1982; 22: 371-376.
116. Masud T., Young V., Charman T. et al. Adaptive responses to very low protein diets: the first comparision of keto-acids to essential amino acids. Kidney int 1994; 45: 1182-1192.
117. Mauer S., Steffer M., Asar S. et al. The effects of Golblatt hypertension on the development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 1978; 27: 738-744.
118. May R., Hara Y., Kelly R. et al. Branched chain amino acid metabolism in rat muscle: Abnormal regulation in acidosis. Am J Physiol 1987; 252: E712-E718.
119. Meisinger E., Strauch M. Controlled trial of two keto-acid supplements on renal function, nutritional status and bone metabolism in uremic patients. Kidney int 1987; 32; Suppl. 22: S170-S173.
120. Mitch W., Walser M., Sapir D. Nitrogen sparing induced by leucine compared with that induced by its keto-analogue, alpha-ketoisocaproate in fasting obese man. J Clin Investing 1981; 67: 553-562.
121. Mitch W., Steinman T., Walser M. The effect of protein restriction plus ketoacids on progression of chronic renal failure. Clin Res 1983; 31: 437.
122. Mitch W., Clark A. Specifity of the effect of leucin and its metabolites on protein degradation in skeletal muscle. Biochem J 1984; 222: 579-586.
123. Mitch W. Dietary protein restriction and progressive renal insufficiency. Am J Kidney Dis 1997; 30 (2): 297-300.
124. Monzani G., Bergegio F., Ciuti R. et al. Lp(a) levels: effects of progressive chronic renal failure and dietary management. J Nephrol 1997; 10: 41-45.
125. Nanra R., Kelson K. Chronic renal failure (CRF) diet without amino acid (AA) supplements in progressive renal disease: a controlled trial. Kidney int 1989; 35: 737.
126. Nath K., Hostetter M., Hostetter T. Ammonia-complement interaction in the pathogenesis progressive renal injury. Kidney int 1989; 36; Suppl. 27: S52-S54.
127. Nelson P., Shankland S. Therapeutics in renal disease: the road ahead for antiproliferaferative targets. Nephron 2006; 103: e6-e15.
128. NKF=K/DOQI Clinical Practice Guideline for Nutrition in Chronic Renal Failure. Am J Kidney Dis 2000; 35; Suppl. 2: S. 60-61.
129. Obrador G., Arora P., Kausz A.T. et al. Pre-end stage disease care in the United States: a state of disrepair. J Am Soc Nephrol 1998; 9: S44-S54.
130. Oldrizzi L., Rugiu C., Valvo E. et al. Progression of renal failure in patients with renal diseases of diverse etiology on protein-restricted diet. Kidney int 1985; V27: 553-557.
131. Paradoyaunakis N., Stefanides C., Patricarea A. et al. The effect of calcium carbonate administration on nitrogen metabolism in patients on hemodialysis. Proc EDTA 1985; 22: 83-87.
132. Pedrini M., Levey A., Lau J. et al. The effect dietary restriction on the progression of diabetic and non-diabetic renal diseases: a meta-analysis. Ann Intern Med 1996; 124: 627-632.
133. Peuchant E., Delmas-Beauvieux M., Dubourg L. et al. Antioxidant effects of supplemented very low protein diet in chronic renal failure. Free Radical Biol Med 1997; 22: 313-320.
134. Prakash S., Pande D., Sharma S. et al. Randomized, double-blind, placebo-controlled trial to evaluate efficacy to ketodiet in predialytic chronic renal failure. J Renal Nutr 2004; 14: 86-96.
135. Rose W. Amino acid requirements in man. Fed Proc 1949; 8: 546-542.
136. Rosman J., Meijer S., Sluiter W. et al. Prospective randomized trial of early dietary protein restriction in chronic renal failure. Lancet 1984; II: 1291-95.
137. Rosman J., ter Wee P. Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purif 1989; 7: 52-57.
138. Schaefer K., Herrath D., Asmus G. et al. The beneficial effect of ketoacids on serum phosphate and parathyroid hormone in patient with chronic uremia. Clin Nephrol 1988; 30; 2: 93-96.
139. Schaefer K., Erley C., von Herrath D., Stein G. Calcium salts of keto-acid as a new treatment strategy for uremic hyperphosphatemia. Kidney int 1989; 36; Suppl. 27: S136-S139.
140. Seifart G., Ensminger A., Scholz R. Increase in body mass during long term bicarbonate dialysis. Kidney int 1987; 31; Suppl. 22: S174-177.
141. Seyer-Hansen J., Gundersen H. Renal hypertrophy in experimental diabetes: a morphometric study. Diabetologia 1980; 18: 501-505.
142. Smadel J., Farr L. The effect of diet on the pathological changes in rats with nephrotoxic nephritis. Am J Physiol 1939; 13: 199-221.
143. Steffes M., Brown D., Maucr S. Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 1978; 27: 35-41.
144. Teoduoru C., Saifer A., Frankel H. Conditioning factors influence evolution of experimental glomerulonephritis in rabbits. Am J Physiol 1954; 193: 457-460.
145. Teplan V., Schück O., Horanova M., Skibova J. Effect of ketoacid-amino supplement on the metabolism and renal elimination of branched chain amino acids in patients with chronic renal insufficiency on low protein diet. Wien klin. Wschr 2000; 112: 876-881.
146. Teplan V., Schück O., Votrula M. et al. Metabolic effects of keto acid-amino acid supplementation in patients with chronic renal insufficiency receiving a low protein diet and recombinant human erythropoietin - randomized controlled trial. Wien klin. Wschr 2001; 113: 661-669.
147. Tom K., Young V., Charman T. et al. Long-term adaptive responses to low protein diet in chronic renal failure. Am J Physiol 1995; 268: F668-F677.
148. Traynor J., Simpson K., Geddes C. et al. Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 2002; 13: 2125-2132.
149. Trevino-Bessera A., Lopez J., Alanis L. Ketoanalogues and a very low-protein diet diminism serum cholesterol in predialysis patients. Dialysis and transplantation 2002; 31: 25-26.
150. Tungsanga K., Kang Ch., Walser M. Utilisation of alpha-ketoisocaproate for protein synthesis in uremic rats. Kidney int 1986; 30: 891-894.
151. United States Renal Date System: The USRDS: Morbidity and Mortality Study Wave 2. Am J Kidney Dis 1997; 30; Suppl. 1: S67-S68.
152. Venderly B., Chauveau P., Barthe N. et al. Nutrition in hemodialysis patients previously on a supplemented very low protein diet. Kidney int 2003; 63: 1491-1498.
153. Verberckmoes R., Van Rerterghem Y. Can the effects of protein restriction on the progression of renal failure also be achieved by pharmacological means? Blood Purif 1989; 7: 58-60.
154. Volhard F. Die doppelseitigen hämatogenen Nierenerkrankungen (Bright'sche Krankheit). Handbuсh der inneren Medezin, Berlin, Springer 1918: S. 1149-1172.
155. Walker W., Gimenez L., Tew W. et al. Prevention of phosphate induced progression of experimental uremia by 3-phosphocitric acid. Proc. 5-th Int. Workshop «Phosphate and other Miner». London: 1982: 157-166.
156. Walser M., La France D., Ward L., Van Duym M. Progression of chronic renal failure in patients given ketoacids following amino acid. Kidney int 1987; 32: 123-128.
157. Walser M. Dietary proteins and their relationship to kidney disease. In book: Dietary proteins in health and disease 1992: 168-178.
158. Walser M. Does prolonged protein restriction preceding dialysis lead to protein malnutrition at the onset of dialysis? Kidney int 1993; 44: 1139-1144.
159. Walser M., Hill S. Can renal replacement be deferred by a supplemented very low protein diet. J Am Soc Nephrol 1999; 10: 110-116.
160. Walser M., Mitch W., Maroni B. et al. Should protein intake be restricted in predialysis patients? Kidney Int 1999; 55: 771-777.
161. Walser M. Is there a role for protein restriction in the treatment of chronic renal failure? Blood Purif 2000; 18: 304-312.
162. Walter F., Addis T. Organ work and organ weight. J Exp Med 1939; 69: 467-483.
163. Williams B., Hattersley J., Layward E., Walls J. Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronical uremia. Kidney int 1991; 40: 779-786.
164. Wiserman M., Bogneetti E., Dodds R. et al. Changes in renal failure in response to protein restriction diet in type 1 (insulin dependent) diabetic patients. Diabetologia 1987; 30: 154-159.
165. Yong G., Keogh J., Parsons F. Plasma amino acids and protein levels in chronic renal failure and changes caused by oral supplemention of essential amino acid. Clin Chim Acta 1975; 61: 205-213.
166. Yoshida Y., Fogo A., Ichicava I. Glomerular hypertrophy has a great impact on glomerular sclerosis than adaptive hyperperfusion in remnant nephrons. Kidney int 1988; 33: 327.
167. Zakar G. The effect of keto acid supplement on the course of chronic renal failure and nutritional parameters in predialysis patients and patients on regular dialysis theraphy: the Hungarian ketosteril cohort study. Wien klin Wschrт 2001; 113: S688-694.
168. Zatz R., Meyer T., Rennke H., Brenner B. Predominance of hemodynamic rather than methabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985; 82: 5963-5967.
Review
For citations:
Ermolenko V.M., Kozlova T.A., Michailova N.A. Influence of low protein diet on progression of chronic renal failure. Nephrology and Dialysis. 2006;8(4):310-320. (In Russ.)
Views:
6
Email this article 